Short Interest in MetaVia Inc. (NASDAQ:MTVA) Expands By 489.9%

MetaVia Inc. (NASDAQ:MTVA) saw a large increase in short interest in the month of May. As of May 29th, there was short interest totaling 408,434 shares, an increase of 489.9% from the May 14th total of 69,235 shares. Based on an average daily volume of 21,957,148 shares, the short-interest ratio is presently 0.0 days. Currently, 8.0% of the shares of the stock are sold short.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on MTVA. Weiss Ratings reiterated a “sell (e+)” rating on shares of MetaVia in a research note on Friday, April 24th. Wall Street Zen raised MetaVia from a “sell” rating to a “hold” rating in a report on Saturday, March 28th. Finally, HC Wainwright reissued a “buy” rating and issued a $20.00 target price on shares of MetaVia in a report on Monday, May 18th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $20.00.

MetaVia Price Performance

Shares of MTVA traded down $0.21 on Friday, hitting $1.81. The company’s stock had a trading volume of 501,978 shares, compared to its average volume of 2,199,065. The company has a market capitalization of $9.32 million, a PE ratio of -0.35 and a beta of 0.92. MetaVia has a fifty-two week low of $0.97 and a fifty-two week high of $19.03. The company has a 50 day moving average price of $1.84 and a 200 day moving average price of $3.62.

MetaVia (NASDAQ:MTVA) last announced its earnings results on Thursday, May 14th. The company reported ($0.79) EPS for the quarter, missing the consensus estimate of ($0.76) by ($0.03). On average, equities analysts forecast that MetaVia will post -2.78 EPS for the current year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in MetaVia stock. Virtu Financial LLC acquired a new position in shares of MetaVia Inc. (NASDAQ:MTVA) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 32,755 shares of the company’s stock, valued at approximately $31,000. Virtu Financial LLC owned approximately 0.14% of MetaVia as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 1.37% of the company’s stock.

About MetaVia

MetaVia Inc is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. MetaVia Inc, formerly known as NeuroBo Pharmaceuticals Inc, is based in CAMBRIDGE, Mass.